PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
06-Mar-2024 Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity at Headquarters with Two New Purpose-Built Facilities Almac Group
06-Mar-2024 Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings Coriolis Pharma Research GmbH
06-Mar-2024 Asceneuron Expands Scientific Advisory Board with World Leading Experts in Neurodegenerative Diseases Asceneuron
06-Mar-2024 Women in Life Science Denmark (WiLD) to host network meeting in collaboration with DANISH BIO to promote equity in the Danish life science industry Women in Life Science Denmark (WiLD)
06-Mar-2024 FDA Clears Beckman Coulter Life Sciences DxFLEX Flow Cytometer Beckman Coulter Life Sciences
06-Mar-2024 Jemperli▼ (dostarlimab) becomes the first immunotherapy treatment to receive NICE recommendation for use, in line with its license, in eligible endometrial cancer patients in first line setting GSK
06-Mar-2024 Elsevier and Iktos partner to deliver an AI-driven synthetic chemistry platform for drug discovery Elsevier
05-Mar-2024 ADARE PHARMA SOLUTIONS TO EXPAND PACKAGING & WAREHOUSING CAPABILITIES IN EUROPE Adare Pharma Solutions
05-Mar-2024 The York Health Economic Consortium will undertake the first UK health economic analysis of Ondine’s Steriwave light-activated antimicrobial to reduce Surgical Site Infections York Health Economics Consortium (YHEC)
05-Mar-2024 Ariceum Therapeutics announces opening of new state-of-the-art laboratory in Berlin providing infrastructure for radiopharmaceutical development activities Ariceum Therapeutics
05-Mar-2024 Fibrocor Therapeutics enters into research and development collaboration with McQuade Center for Strategic Research and Development to advance Alport Syndrome program Fibrocor Therapeutics Inc
05-Mar-2024 Transgene, NEC and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050 Transgene
05-Mar-2024 Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders Lundbeck A/S
05-Mar-2024 ViiV Healthcare presents phase I clinical trial findings of a cabotegravir long-acting injectable investigational formulation allowing at least four months between doses ViiV Healthcare
05-Mar-2024 RDS secures CE mark for MultiSense® Remote Patient Monitoring solution Andrew Lloyd Associates
05-Mar-2024 NovAliX and Max Planck join forces to advance Cryo-EM driven drug discovery  Andrew Lloyd Associates
04-Mar-2024 CSL Behring Signs First Commercial Agreement in Austria to Fund Haemophilia B Gene Therapy HEMGENIX® CSL Behring
04-Mar-2024 Carthera: positive results from phase I/II clinical trial of SonoCloud-9 in treatment of glioblastoma published in Nature Communications Andrew Lloyd Associates
04-Mar-2024 Q&M Dental Group recorded growth in both Revenue and Net Profit after tax attributable to parent of S$182.7 million and S$11.5 million respectively for FY2023 Q&M Dental Group Singapore Ltd
04-Mar-2024 Alfa Chemistry Diversifies Supply of Active Pharmaceutical Ingredients for Pharmaceutical Preparation Alfa Chemistry